MHRA Introduces New Device Registration Fee: What Manufacturers Need to Know
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has updated its “DORS Fees Guidance 2.1”, introducing a new annual fee model for device registration.
MedNet EC-REP
Author

From One-Time to Annual Fee
- Until 31 March 2026, MHRA continues to apply the existing £261 one-off registration fee.
- From 1 April 2026, a recurring annual fee will replace the one-off fee, based on the number of chargeable GMDN® Level 2 categories (or Level 1 if Level 2 is not defined).
- Fees will apply per category rather than per device, with pro-rata charges for new devices added mid-year.
Fee Calculation and Payment
- Annual fees are estimated at around £300 per GMDN category.
- MHRA will base fees on a snapshot of registered categories on 31 March each year.
- Payment is due within 90 days of invoicing, and non-payment may suspend registration access.
Changes and Exemptions
- Updating Letters of Designation, organisation name, or address will no longer incur fees.
- Re-registering devices in previously paid categories will not trigger additional charges.
- Only registration of new devices in chargeable categories triggers fees.
Preparing for the New System
Manufacturers and UK Responsible Persons should:
- Review device portfolios and ensure correct GMDN® category assignments before 30 March 2026.
- Verify contact and company information in the MHRA DORS system.
- Plan for the annual payment cycle, starting from 1 April 2026, and budget accordingly.
The shift to an annual fee model supports enhanced post-market surveillance, sustainable regulatory oversight, and encourages accurate device registrations.
Source: MHRA
Related Articles

Well-Established Technologies Under the MDR: EU Commission Expands Exemption List
The EU Commission has expanded the WET list under the MDR, easing requirements for certain class II and class III devices.

MHRA Device Registration: New Clarification on "Placing on the Market" and "Putting into Service" (Update 20 July 2026)
MHRA clarifies medical device registration: 20 July 2026 update explains "placing on the market" vs. "putting into service" in GB.

EC REP Becomes EU REP: What the New Authorised Representative Symbol Means for Medical Device Manufacturers
In short: On 17 June 2026, the European Commission published the reference of EN ISO 15223-1:2021/A1:2025 in the Official Journal of the European Union (OJEU) for both the MDR and the IVDR. This amendment replaces the long-standing "EC REP" symbol with "EU REP" for the authorised representative in the European Union. The change is purely editorial, and you have a five-year transition period - until 17 June 2031 - during which both symbols remain valid.
Stay Updated
Get the latest regulatory updates and industry insights delivered to your inbox.
Subscribe to Updates